Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector



Science Translational Medicine


👁  187700 Views

 113 Reviews  

 Open Access      SCIE      Official Website     Submission Website
Return to Search
 

*Average Peer Review
About 1.0 month(s)
*Competitiveness
Very difficult
CiteScore
27.9

CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: General Medicine
9 / 668
98%



Country/Area of Publication
UNITED STATES
Publication Frequency
Weekly
Publisher
American Association for the Advancement of Science

ISSN
1946-6234
E-ISSN
1946-6242
Year Publication Started
2009

Self-citation (2024-2025)
0.70%
Annual Article Volume
274
Gold OA Percentage
4.61%


Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A

Journal Aim & Scope
Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.


Web of Science Quartiles
WOS Quartile: Q1

Quartiles By JIFCollectionQuartileRankPercentage
Category: CELL BIOLOGYSCIEQ114/204
93.4%
Category: MEDICINE, RESEARCH & EXPERIMENTALSCIEQ13/195
98.7%
Quartiles By JCICollectionQuartileRankPercentage
Category: CELL BIOLOGYSCIEQ19/204
95.83%
Category: MEDICINE, RESEARCH & EXPERIMENTALSCIEQ12/195
99.23%
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology016.10
    Stem Cell Research & Therapy5613.30
    EXPERT REVIEWS IN MOLECULAR MEDICINE738.70
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE1088.70
    Frontiers of Medicine288.20
    Journal of Diabetes Research337.20
    Journal of Cardiovascular Translational Research446.10
    Biomed Research International947.90
    JOURNAL OF INVESTIGATIVE MEDICINE598.60
    American Journal of Translational Research455.30
  • Science Translational Medicine Science Translational Medicine
    Predict CiteScore Trend:
    Steady Increase No Change Gradual Decline  Refresh
 
    👁  187700 Views
      113 Reviews        
 
 
 

Select your rating and start your review of Science Translational Medicine

 

    地铁二号线
    Status: Accepted

    2025-05-02

    Submitted on July 26, 2023, revised and resubmitted on September 26, 2023, because the experiment was too difficult, so an additional year was given to complete the experiments. Reuploaded on October 8, 2024. Revised on November 26, 2024, and essentially accepted in principle, although no acceptance email was received. However, formatting needed to be changed due to the extensive amount of experiments that had been added. The monkey experiments were essentially redone, with 1.5 times the workload required by the reviewers and editors. Revised again on December 8, 2024, and then there was no communication for a while. A reminder was sent, but no response was received. After carefully studying the time cycle of the STM, it was discovered that it usually takes about six months after a revision to receive acceptance. This led to a painful waiting period, possibly due to a backlog of manuscripts. An email arrived on April 20, 2025, requesting revisions to be completed by April 28, 2025, for publication scheduling purposes. The editor made very detailed changes, scrutinizing the grammar and individual words, and raised numerous questions that needed to be confirmed and answered. It was almost unbearable, with almost a week of pulling all-nighters. The revisions were completed on the afternoon of April 28, 2025. Two minor issues were raised on April 29, and were promptly addressed in an email response the same day. The paper was finally accepted on April 30, 2025, after a total of 1 year and 9 months from submission to acceptance. It was an emotional rollercoaster. In summary, STM is very demanding in terms of innovation, requiring high levels of creativity in both ideas and methods. The data is extensive, with potential for translation, and it is preferable to have experiments on large animals, especially primates. The editorial standards are truly high, and after several rounds of revisions, the article appeared to have been elevated several levels.




    Adelaide Lawson
    Status: N/A

    2024-11-30

    The time period is indeed not short, so you can send an email to remind them.




    稻妻向凝
    Status: N/A

    2024-10-31

    There will definitely be a good outcome!




    Herbert Lucy
    Status: N/A

    2024-10-27

    Research focus: Translational medicine; Medical experience sharing: It has been almost four months, give a definite answer, whether it is life or death.




    奉天睿博
    Status: N/A

    2024-10-11

    May I ask if STM requires all authors' agreement to proceed to the next step? The assignment editor has been under evaluation for several days and there has been no change.




    小野寺心慈
    Status: N/A

    2024-09-25

    Not in the same league as cc.




    Adelaide Lawson
    Status: N/A

    2024-09-12

    This is not certain, if you need more information, please contact the editorial department for inquiries.




    Adelaide Lawson
    Status: N/A

    2024-09-12

    The paper has been submitted to the editorial consultant for review.




    稻妻向凝
    Status: N/A

    2024-09-11

    How many external committees are usually appointed?




    稻妻向凝
    Status: N/A

    2024-09-04

    By editing this level, it has been submitted to the external review committee. The next step is to consider the feedback from the external review committee to determine if it should be submitted for review.




Journals In The Same Field
CA-A CANCER JOURNAL FOR CLINICIANS
CiteScore: 1154.20

NATURE REVIEWS DRUG DISCOVERY
CiteScore: 181.80

MMWR Recommendations and Reports
CiteScore: 129.90

Nature Reviews Clinical Oncology
CiteScore: 114.50

Nature Reviews Disease Primers
CiteScore: 113.30

NATURE REVIEWS CANCER
CiteScore: 103.80

NEW ENGLAND JOURNAL OF MEDICINE
CiteScore: 96.40

LANCET
CiteScore: 87.60

NATURE REVIEWS IMMUNOLOGY
CiteScore: 84.70

NATURE MEDICINE
CiteScore: 82.40



© 2010-2025  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
PrivacyTerms of Servic